IFNG and neoplasm: Macrophages can be activated by interferon gamma (IFNγ) and Toll-like receptor (TLR) agonists to develop an inflammatory (M1-like) phenotype, thus exhibiting proinflammatory characteristics with microbial killing and tumor growth inhibition (6, 7).